User profiles for G. Sebastiani

Gian Domenico sebastiani

- Verified email at scamilloforlanini.rm.it - Cited by 11045

Giada Sebastiani

- Verified email at mcgill.ca - Cited by 9953

Guido Sebastiani, M.Sc. Ph.D.

- Verified email at unisi.it - Cited by 3667

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis

…, M Soni, LJ Prokop, Z Younossi, G Sebastiani… - Hepatology, 2017 - journals.lww.com
Liver fibrosis is the most important predictor of mortality in nonalcoholic fatty liver disease (NAFLD).
Quantitative risk of mortality by fibrosis stage has not been systematically evaluated. …

[HTML][HTML] Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

…, VWS Wong, N Peleg, A Shlomai, G Sebastiani… - Gastroenterology, 2020 - Elsevier
Background & Aims Biopsy-confirmed liver fibrosis is a prognostic factor for patients with
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …

The technology of incremental sheet forming—a brief review of the history

WC Emmens, G Sebastiani… - Journal of Materials …, 2010 - Elsevier
This paper describes the history of Incremental Sheet Forming (ISF) focusing on technological
developments. These developments are in general protected by patents, so the paper can …

Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Arthritis & …, 2002 - Wiley Online Library
Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients

R Cervera, MA Khamashta, J Font, GD SEBASTIANI… - Medicine, 1993 - journals.lww.com
… ); Department of Immunology, Medical School of Ankara University, Ankara, Turkey (OA);
Department of Connective Tissue Diseases, Institute of Rheumatology, Warsaw, Poland (AJ-G.)…

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.

…, G Govoni, S Gauthier, G Sebastiani… - The Journal of …, 1995 - rupress.org
In mice, natural resistance or susceptibility to infection with intracellular parasites is
determined by a locus or group of loci on chromosome 1, designated Bcg, Lsh, and Ity, which …

Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients

R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 1999 - journals.lww.com
… Divisione di Reumatologia, Ospedale San Camillo de Lellis, Rome, Italy: Gian Domenico
Sebastiani. Department of Immunology, Medical School of Ankara University, Ankara, Turkey: …

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Annals of the …, 2010 - ard.bmj.com
g) than in the HD group (9.5 g; p<0.001 by unpaired t test). Of note, 68% of the patients
randomised to the LD IVCY arm did not receive more than the per protocol IVCY regimen—that is…

Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis …

…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Arthritis & …, 2004 - Wiley Online Library
Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …